What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

TERN Insider Trading (Terns Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $19,380,000.00
Insider Selling (Last 12 Months): $0.00

Terns Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Terns Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Terns Pharmaceuticals Share Price & Price History

Current Price: $10.08
Price Change: Price Increase of +0.28 (2.86%)
As of 10/19/2021 01:00 AM ET

This chart shows the closing price history over time for TERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"

Terns Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2021James E FlynnInsiderBuy665,000$17.00$11,305,000.00
2/9/2021Vivo Capital Fund Viii, L.P.Major ShareholderBuy475,000$17.00$8,075,000.00
See Full Table
Insider Selling at Terns Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Terns Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

66.14% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Terns Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley26,831$0.33M0.0%N/A0.107%Search for SEC Filing on Google Icon
8/17/2021Samsara BioCapital LLC289,068$3.54M0.4%-41.9%1.151%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC14,769$0.18M0.0%N/A0.059%Search for SEC Filing on Google Icon
8/17/2021Balyasny Asset Management LLC10,308$0.13M0.0%N/A0.041%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC18,200$0.22M0.0%-44.2%0.072%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP20,447$0.25M0.0%-94.2%0.081%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE4,975$61K0.0%-47.6%0.020%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System12,038$0.15M0.0%-8.4%0.048%Search for SEC Filing on Google Icon
8/16/2021Antara Capital LP775,934$9.51M0.5%+3.2%3.090%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley26,831$0.33M0.0%N/A0.107%Search for SEC Filing on Google Icon
8/16/2021State Street Corp128,703$1.58M0.0%+30.5%0.512%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp86,783$1.06M0.0%-5.5%0.346%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC143,069$1.75M0.0%+9.8%0.570%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.415,730$5.10M0.0%-27.8%1.655%Search for SEC Filing on Google Icon
8/13/2021FMR LLC3,022,557$37.06M0.0%+4.7%12.036%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.11,419$0.14M0.0%-51.5%0.045%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp23,286$0.29M0.0%+20.8%0.093%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.437,604$5.37M0.0%+7.4%1.743%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund5,869$72K0.0%+50.5%0.023%Search for SEC Filing on Google Icon
5/18/2021PFM Health Sciences LP329,274$7.24M0.2%N/A1.311%Search for SEC Filing on Google Icon
5/18/2021Zimmer Partners LP22,500$0.50M0.0%N/A0.090%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC3,791,204$83.41M0.8%N/A15.089%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC32,621$0.72M0.0%N/A0.130%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System13,135$0.29M0.0%N/A0.052%Search for SEC Filing on Google Icon
5/18/2021Samsara BioCapital LLC497,555$10.95M2.0%N/A1.980%Search for SEC Filing on Google Icon
5/17/2021Vivo Capital LLC2,675,133$58.85M2.1%N/A10.647%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C2,345,959$51.61M1.1%N/A9.337%Search for SEC Filing on Google Icon
5/17/2021Suvretta Capital Management LLC1,125,136$24.75M0.4%N/A4.478%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP350,000$7.70M0.1%N/A1.393%Search for SEC Filing on Google Icon
5/17/2021Pinz Capital Management LP19,948$0.44M0.1%N/A0.079%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC14,085$0.31M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.70,000$1.54M0.1%N/A0.279%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP15,000$0.33M0.0%N/A0.060%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp19,279$0.42M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp91,787$2.02M0.0%N/A0.365%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC130,263$2.87M0.0%N/A0.518%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.23,536$0.52M0.0%N/A0.094%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG2,546$56K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund3,900$86K0.0%N/A0.016%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.407,349$8.96M0.0%N/A1.621%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.5,075$0.11M0.0%N/A0.020%Search for SEC Filing on Google Icon
5/6/2021Matthews International Capital Management LLC1,071,421$23.57M1.0%N/A4.264%Search for SEC Filing on Google Icon
5/4/2021Cowen AND Company LLC25,000$0.55M0.0%N/A0.100%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. It develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase I clinical trial for the treatment of NASH. The company also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and GLP-1R, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to address metabolic processes involved in the pathogenesis of NASH. Terns Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Foster City, California.
Read More on Terns Pharmaceuticals

Today's Range

Now: $10.08
Low: $9.81
High: $10.08

50 Day Range

MA: $11.04
Low: $9.51
High: $13.46

52 Week Range

Now: $10.08
Low: $6.91
High: $28.36

Volume

9,233 shs

Average Volume

105,206 shs

Market Capitalization

$253.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?

Terns Pharmaceuticals' top insider shareholders include:
  1. James E Flynn (Insider)
  2. Vivo Capital Fund Viii, LP (Major Shareholder)
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"